Quick Answer
INTERPACE BIOSCIENCES, INC. reported Research And Development Expense of $642.0 thousand for the year ending 2025.
- INTERPACE BIOSCIENCES, INC. showed a decrease of -5.0% in Research And Development Expense from 2024 to 2025.
- This data is from INTERPACE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), INTERPACE BIOSCIENCES, INC.'s Research And Development Expense has grown by 151.8%.
- Historical annual values: Fiscal year 2025: $642.0 thousand | Fiscal year 2024: $676.0 thousand | Fiscal year 2023: $636.0 thousand | Fiscal year 2022: $703.0 thousand | Fiscal year 2021: $1.49 million | Fiscal year 2020: $2.80 million | Fiscal year 2019: $2.81 million | Fiscal year 2018: $2.12 million | Fiscal year 2017: $1.46 million | Fiscal year 2016: $1.65 million | Fiscal year 2015: $2.29 million | Fiscal year 2014: $255.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: